Estimating Decision-Relevant Comparative Effects Using Instrumental Variables

Statistics in Biosciences

Volumn 3, Issue 1, 2011, Pages 6-27

  Basu, Anirban ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Breast cancer; Heterogeneity; Instrumental variables; Local IV methods; Survival

Indexed keywords

AGE; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; HUMAN; INSTRUMENTAL VARIABLE ANALYSIS; MARGINAL TREATMENT EFFECT; MASTECTOMY; MEDICARE; OBSERVATIONAL STUDY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; SAMPLE; STATISTICAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 80053053636     PISSN: 18671764     EISSN: 18671772     Source Type: Journal    
DOI: 10.1007/s12561-011-9033-6     Document Type: Article

References (48)

1. Amemiya T (1974) The non-linear two-stage least squares estimator. J Econom 105-110.
2. Angrist J, Imbens G, Rubin D (1996) Identification of causal effects using instrumental variables. J Am Stat Assoc 91: 444-455.
3. Bang H, Robins JM (2005) Doubly robust estimation in missing data and causal inference models. Biometrics 61: 962-972.
4. Basu A (2009) Individualization at the heart of comparative effectiveness research: the time for i-CER has come. Med Decis Mak 29(6): N9-N11.
5. Basu A, Heckman J, Navarro-Lozano S, Urzua S (2007) Use of instrumental variables in the presence of heterogeneity and self-selection: an application to treatments of breast cancer patients. Health Econ 16(11): 1133-1157.
6. Basu A, Philipson T (2010) Impact of comparative effectiveness research on health and healthcare spending. NBER working paper No. w15633.
7. Björklund A, Moffitt R (1987) The estimation of wage gains and welfare gains in self-selection. Rev Econ Stat 69(1): 42-49.
8. Blundell R, Powell J (2003) Endogeneity in nonparametric and semiparametric regression models. In: Hansen L, Dewatripont M, Turnovsky SJ (eds) Advances in economics and econometrics. Cambridge University Press, Cambridge, pp 312-357.
9. Brooks JM, Chrischilles E, Scott S, Chen-Hardee S (2003) Was lumpectomy underutilized for early stage breast cancer? Instrumental variables evidence for stage II patients from Iowa. Health Serv Res 38(6): 1385-1402. Part I.
10. Earle CE, Tsai JS, Gelber RD, Weinstein MC, Neumann PJ, Weeks JC (2001) Effectiveness of chemotherapy for advanced lung cancer in the elderly: instrument variable and propensity analysis. J Clin Oncol 19(4): 1064-1070.
11. Fisher B, Bauer M, Margolese R et al. (1985) Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 312: 665-673.
12. Franklin BA (2008) Lessons learned from the COURAGE trial: generalizability, limitations, and implications. Prev Cardiol 11(1): 5-7.
13. Hadley J, Mitchell JM, Mandelblatt J (1992) Medicare fees and small area variations in the treatment of localized breast cancer. N Engl J Med 52: 334-360.
14. Hadley J, Polsky D, Mandelblatt JS, Mitchell JM, Weeks JC, Wang Q, Hwang Y-T, OPTIONS Research Team (2003) An exploratory instrumental variable analysis of the outcomes of localized breast cancer treatments in a Medicare population. Health Econ 12: 171-186.
15. Heckman JJ (1996) Comments on angrist, imbens, and rubin: identification of causal effects using instrumental variables. J Am Stat Assoc 91: 434.
16. Heckman J (1997) Instrumental variables: a study of implicit behavioral assumptions used in making program evaluations. J Hum Resour 32(3): 441-462.
17. Heckman J (2001) Micro data, heterogeneity, and the evaluation of public policy: Nobel Lecture. J Polit Econ 109(4): 673-748.
18. Heckman J, Honore B (1990) The empirical content of the Roy model. Econometrica 58: 1121-1149.
19. Heckman JJ, Vytlacil EJ (1999) Local instrumental variables and latent variable models for identifying and bounding treatment effects. Proc Natl Acad Sci USA 96(8): 4730-4734.
20. Heckman J, Vytlacil E (2005) Econometric evaluation of social programs. In: Heckman J, Leamer E (eds) Handbook of econometrics, vol 6. Elsevier, Amsterdam.
21. Heckman J, Vytlacil E (2005) Structural equations, treatment effects and econometric policy evaluation. Econometrica 73(3): 669-738.
22. Heckman J, Vytlacil EJ (2007) Econometric evaluation of social programs, part II: using the marginal treatment effect to organize alternative econometric estimators to evaluate social programs, and to forecast their effects in new environments. In: Heckman J, Leamer E (eds) Handbook of econometrics, vol 6B. Elsevier, Amsterdam.
23. Heckman JJ, Urzua S, Vytlacil E (2006) Understanding instrumental variables in models with essential heterogeneity. Rev Econ Stat 88(3): 389-432.
24. Hernan MA, Alonso A, Logan R et al. (2008) Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease. Epidemiology 19: 766-779.
25. Humphrey LL, Chan BK, Sox HC (2002) Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease. Ann Intern Med 137: 273-84.
26. Imbens G, Angrist J (1994) Identification and estimation of local average treatment effects. Econometrica 62(2): 467-475.
27. McClellan M, McNeil B, Newhouse J (1994) Does more intensive treatment of acute myocardial infarction reduce mortality? JAMA 272(11): 859-866.
28. McFadden D (1973) Conditional logit analysis of qualitative choice behavior. In: Zarembka P (ed) Frontiers in econometrics. Academic Press, New York.
29. McFadden D (1981) Econometric models of probabilistic choice. In: Manski CF, McFadden D (eds) Structural analysis of discrete data with econometric applications. MIT Press, Cambridge.
30. Mullahy J (1997) Instrumental variable estimation of count data models: applications to models of cigarette smoking behavior. Rev Econ Stat 79: 586-593.
31. Quandt RE (1972) A new approach to estimating switching regression. J Am Stat Assoc 67(338): 306-310.
32. Quandt RE (1958) The estimation of parameters of a linear regression system obeying two separate regimes. J Am Stat Assoc 53(284): 873-880.
33. Polsky D, Mandelblatt JS, Weeks J, Venditti L, Hwang YT, Glick HA, Hadley J, Schulman KA (2003) Economic evaluation of breast cancer treatment: considering the value of patient choice. J Clin Oncol 21: 1139-1146.
34. Robins JM, Rotnitzky A, Zhao LP (1995) Analysis of semiparametric regression models for repeated outcomes in the presence of missing data. J Am Stat Assoc 90: 106-121.
35. Rossouw JE, Anderson GL, Prentice RL et al. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 288: 321-33.
36. Rosenbaum PR, Rubin D (1983) The central role of the propensity score in observational studies for causal effects. Biometrika 70: 41-55.
37. Roy AD (1951) Some thoughts on the distribution of earnings. Oxf Econ Pap 3: 135-146.
38. Rubin D (1973) The use of matched sampling and regression adjustment to remove bias in observational studies. Biometrics 29: 185-203.
39. Rubin DB (1997) Estimating causal effects from large data sets using propensity scores. Ann Intern Med 127: 757-763.
40. Scharfstein DO, Rotnitzky A, Robins JM (1994) Adjusting for nonignorable drop-out using semiparametric nonresponse models. J Am Stat Assoc 94: 1096-1120 (with rejoinder, 1135-1146).
41. Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer (1998) Mastectomy or lumpectomy? The choice of operation for clinical stages I and II breast cancer. Can Med Assoc J 158(Suppl. 3): S15-S21.
42. Stock JH, Trebbi F (2003) Who invented instrumental variable regression? J Econ Perspect 17(3): 177-194.
43. Stukel TA, Fisher ES, Wennberg DE, Alter DA, Gottlieb DJ, Vermeulen MJ (2007) Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. JAMA 297: 278-285.
44. Sturmer T, Schneeweiss S, Rothman KJ, Avorn J, Glynn RJ (2007) Performance of propensity score calibration-a simulation study. Am J Epidemiol 165: 1110-1118.
45. Terza JV, Basu A, Rathouz PJ (2008) Two-stage residual inclusion estimation: addressing endogeneity in health econometric modeling. J Health Econ 27(3): 531-543.
46. Vanness DJ, Mullahy J (2006) Perspectives on mean-based evaluation of health care. In: Jones A (ed) The Elgar companion to health economics. Edward Elgar Publishing, Cheltenham.
47. Virnig BA et al (2007) Increased use of breast-conserving surgery: preferred treatment or failure to provide adequate local therapy? Breast Cancer Res Treat 106 (Supp 1): Abstract 4065.
48. Yitzhaki S (1989) On using linear regression in welfare economics. Working paper 217, Department of Economics, Hebrew University.